What happens when academia and industry come together to share their passion for innovation and discovery? This synergy was sparked at the MCB Industrial Affiliates Program (IAP) inaugural symposium.
Below are articles from various sources about members of MCB and their research.
A group of UC researchers received funding to build the NexGen 7T functional MRI (fMRI) that will "provide the highest resolution images of the brain ever obtained, able to focus on a region the size of a poppy seed."
Assistant Professor of Genetics, Genomics and Development Hernan Garcia and Assistant Adjunct Professor of Biochemistry, Biophysics and Structural Biology Jacob Corn received New Innovator Awards from the National Institutes of Health (NIH). The award supports highly creative, innovative research that could have implications for human health.
A study co-authored by MCB and Chemistry Professor, and HHMI Investigator, Jennifer Doudna details a safer and more effective method of delivering CRISPR-Cas9 gene-editing technology.
We have just learned that MCB Emeritus Professor Satyabrata Nandi passed away on July 29th, 2017 in his home in Berkeley at the age of 86. He received his PhD from UC Berkeley in 1957, and ultimately joined us as a faculty member. His career in cancer research and teaching spanned over 40 years and he is still remembered fondly in the department.
The lab of MCB Associate Professor Michelle Chang has engineered E. coli to manufacture bioplastics from inorganic fluorides. The product is more durable than non-fluorinated commercial bioplastics, which could make bioplastic production more sustainable.
A study co-authored by Associate Professor of MCB and Physics Ahmet Yildiz has revealed a critical region within the Cas9 protein that can be manipulated to improve its target specificity. This has the potential to greatly reduce the risk of inaccurate edits, a key consideration for the future of gene therapy in humans.
4D Molecular Therapeutics, co-founded by MCB & BioEngineering Professor David Schaffer has received $3 million in funding from Cystic Fibrosis Foundation Therapeutics Inc.
4D Molecular Therapeutics is a developer and manufacturer of gene therapeutic products. The funding will help them begin clinical trials of a new gene therapy treatment, 4D-710, on cystic fibrosis patients.
Congratulations to Florentine Rutaganira (postdoc in Professor Nicole King's Lab), who has been named an HHMI Hanna Gray Fellow. HHMI’s Hanna H. Gray Fellows Program seeks to encourage talented early career scientists who have the potential to become leaders in academic research. Each of the 15 fellows will get up to $1.4M in funding covering Post-doc and assistant professor transitions.
The lab of MCB Associate Professor Dan Nomura (also affiliated with Chemistry and Nutritional Sciences & Toxicology) has determined how a natural product results in the suppression of breast cancer tumor growth, and developed a synthetic molecule to mimic its effect. MCB graduate student, Carl Ward, was one of the first authors on this paper.
This research can help develop new methods of synthesizing effective cancer treatments from natural products.
A team of researchers led by MCB Professor and HHMI Investigator Eva Nogales has successfully resolved the 3-D structure of transcription factor IIH (TFIIH) using cryo-electron microscopy at near atomic resolution.
This new technique allows structural biologists to visualize how specific molecules interact with target proteins in cells, and how protein mutations affect cell function.
Are you interested in building relationships with local industry companies looking to engage with the MCB research community? Join us for the next MCB Industrial Affiliates Program (IAP) event on September 22nd. The symposium will feature presentations by industry partners about career opportunities within their companies well as an interactive poster session highlighting the research of MCB students and postdocs. Please contact email@example.com for event details or visit our website to learn more about the program.
Sophomores Nissma Bencheikh (intended MCB major) and Roaya Jannatipour (intended IB major) became fast friends at Berkeley their freshman year. But it turns out they had a lot more in common than their love for biology!